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Abstract
African trypanosomiasis is a severe parasitic disease that affects both humans and livestock. Several different species may
cause animal trypanosomosis and although Trypanosoma vivax (sub-genus Duttonella) is currently responsible for the vast
majority of debilitating cases causing great economic hardship in West Africa and South America, little is known about its
biology and interaction with its hosts. Relatively speaking, T. vivax has been more than neglected despite an urgent need to
develop efficient control strategies. Some pioneering rodent models were developed to circumvent the difficulties of
working with livestock, but disappointedly were for the most part discontinued decades ago. To gain more insight into the
biology of T. vivax, its interactions with the host and consequently its pathogenesis, we have developed a number of
reproducible murine models using a parasite isolate that is infectious for rodents. Firstly, we analyzed the parasitical
characteristics of the infection using inbred and outbred mouse strains to compare the impact of host genetic background
on the infection and on survival rates. Hematological studies showed that the infection gave rise to severe anemia, and
histopathological investigations in various organs showed multifocal inflammatory infiltrates associated with extramedullary
hematopoiesis in the liver, and cerebral edema. The models developed are consistent with field observations and pave the
way for subsequent in-depth studies into the pathogenesis of T. vivax - trypanosomosis.
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Introduction
African trypanosomiasis, one of the most neglected diseases,
consists of a number of important human and animal pathologies
caused by parasitic protists of the order Kinetoplastida. Human
African Trypanosomiasis (HAT), or sleeping sickness, and animal
trypanosomosis, or Nagana, are vector-borne diseases, that are
primarily cyclically transmitted by tsetse flies. HAT is a major
public health problem in 35 sub-Saharan countries. The related
animal challenge, caused by several species, i.e. Trypanosoma vivax,
Trypanosoma congolense and to a lesser extent to Trypanosoma brucei
brucei causes about 3 million deaths annually in cattle and has a
marked impact on African agriculture, causing annual livestock
production losses of about US$ 1.2 billion. T. vivax accounts for up
to half of total Trypanosoma prevalence in West Africa where it is
considered the major pathogen for livestock and small ruminants
[1,2,3]. Outside tsetse endemic areas, West African T. vivax isolates
were introduced long ago into South American countries where it
represents a real threat since it can be efficiently transmitted across
vertebrate hosts by mechanical means and by various biting flies
and tabanids [4,5,6].
The severity of the disease depends on parasite strain,
endemicity and host species, but the key steps in the T. vivax -
host interactions are still largely unknown. Several pieces of
evidence point to the importance of host genetic factors in
determining individual susceptibility and/or resistance to this
infection [3,7,8,9,10,11]. Trypanotolerance is defined as the ability
demonstrated by cattle of different genetic backgrounds to control
trypanosomosis [12,13]. It has previously been reported that
increased bovine resistance to trypanosomosis is associated with
more control over parasitemia and related anemia, two of the
main pathogenic effects of trypanosome infections [14,15].
However, dissimilar courses of the infection may be due to genetic
polymorphism and to the virulence of the parasite isolates, thus
leading to moderate, progressive and/or lethal pathologies and
therefore affecting mortality rates [5,6,7].
It is widely accepted that if trypanosomosis is to be successfully
treated in the field, a number of parameters must be taken into
account, including the seasonal trypanosome prevalence and
vector abundance, the severity of the disease, the magnitude of the
anemia, the stock nutritional state and the prescription of an
appropriate trypanocidal drug [6,16,17,18]. However, the anti-
genic complexity of trypanosomes, their ability to expose a variety
of genetically-controlled surface coat antigens (VSG), and the
diversity of the immune responses presented by unrelated hosts
[19,20,21], call for the discovery of new parasite genetic markers
www.plosntds.org 1 August 2010 | Volume 4 | Issue 8 | e792and more in-depth knowledge of host trypanotolerance mecha-
nisms.
Several early studies were conducted in more affordable mouse
or rat experimental models of infection in attempts to throw light
on trypanotolerance, antigenic variation, the pathogenesis of
intravascular coagulation, and T. vivax immunobiology and
dynamics [7,11,19,22,23,24,25]. However, these studies used a
variety of more or less virulent isolates from cattle, goats, sheep,
horses and donkeys to explore the ability of T. vivax stocks to infect
several intact or immunosuppressed mouse strains. Although these
studies had a huge impact on research into T. vivax, the diversity of
the results they yielded and the difficulties encountered in
establishing axenic parasite cultures or reliable in vivo infections
that entirely resemble natural infections [26], constrained the work
performed with these models. In consequence, more than 20 years
ago, while biological investigations into VSG and the identification
of serodemas were usual for more than a few trypanosomes of the
Trypanozoon subgenus, studies on T. (Dutonella) vivax VSG molecules
and structure of the coat were just been encouraged [26].
Research into T. vivax then focused on characterizing parasite
surface proteins or comparing genetic diversity of Western to
Eastern African parasite stocks and more recently on analyzing
population clonality, [10,27,28,29,30,31,32,33], but somehow
neglected the further development of suitable rodent models.
Now, and in an attempt to circumvent the major constraints
inherent to studying T. vivax/host interactions in the field and data
inconsistencies arising from the difficulties encountered in the past,
we have developed in vivo murine models of trypanosomosis using a
T. vivax isolate known to maintain infectivity to rodents [23]. Here
we show that this T. vivax isolate retains its original characteristics
after several years of cryopreservation. The parasites can grow,
multiply and be transmitted in vivo following predictable kinetics in
the peripheral blood of different mouse strains selected for their
susceptibility or resistance to different parasite inocula. Sustained
and reproducible infections are obtained that successfully mimic
the dynamics of the parasitological, histological and pathological
features of the infection and closely resembling those observed for
cattle trypanosomosis in the field. We have thus developed reliable
mouse research models that can be used to elucidate the
immunopathological mechanisms involved in T. vivax infection
and associated disease. It is worth noting that T. vivax was recently
shown to express a functional gene involved in the non specific
polyclonal activation of host B cells and that this gene is absent in
more widely studied T. brucei and T. congolense [34]. Furthermore,
the work presented here is expected to be a useful and
complementary tool for the further studies of T. vivax immuno-
biology and will thus provide valuable information about
trypanotolerance, Trypanosoma evasion strategies from host im-
mune system, and immunopathogenesis.
Materials and Methods
T. vivax parasites and oligonucleotides
Trypanosoma (Dutonella) vivax stabilates (STIB 731-A), cryopre-
served on September 25, 1996 after 9 passages in mice, were
kindly provided by R. Brun (Swiss Tropical Institute, Basel,
Switzerland). STIB 731-A stabilates were originally prepared in
November 1982 using bloodstream forms of IL 1392 T. vivax stock
obtained from the blood of goat #M918, at ILRAD (ILRI),
Nairobi, Kenya. This West African IL 1392 goat stock was derived
from the Zaria Y486 Nigerian isolate of a naturally infected Zebu
steer maintained by 62 serial passages in mice [23]. VSG ILDat
1.2 (ILRAD Duttonella antigen type 1.2) specific primers were
deduced from the VSG ILDat 1.2 full length sequence
(TvY486_0004810 variant surface glycoprotein putative,
1215 bp) obtained from the GeneDB of the Zaria Y486
Trypanosoma vivax nuclear genome (Sanger Institute Pathogen
Sequencing Unit (PSU), http://www.sanger.ac.uk/Projects/T_
vivax/): VSG-1.2F (59 AATTTTGGTGAGTGTCGGTGT 3’)
and VSG-1.2R (5’ ATTTCCTCCACCACGTAGCTC 3’). T.
vivax- specific forward and reverse ribosomal promoter primers
were also deduced from the Zaria Y486 chromosome 3:
TvrDNAF (5’ CTGATTTCGCCACTGCTATTATTTGC 3’)
and TvrDNAR (5’ CGCTTCACTTGATGATCGTTTCG 3’),
respectively. Parasites were maintained by weekly passages in mice
and new stabilates were appropriately and regularly frozen in
polysoma buffer/glycerol, as previously described [11]. Blood
smears were prepared from infected mouse blood, air dried, fixed
in methanol for 5 minutes and further stained with 5% Giemsa for
20 minutes.
Mice and infections
Seven to 10-week-old male BALB/c (H2
d), C57BL/6 (H2
b)o r
Swiss outbred (CD-1, RJOrl:SWISS) mice (Janvier, France) were
used in all the studies. Mice were injected intraperitoneally with
10
1–10
5 bloodstream forms of T. vivax obtained at the peak of
parasitemia (day 8 post infection). For parasite enumeration, five
microliters of blood were harvested individually from the tail vein
and appropriately diluted in buffered saline when necessary. Blood
parasite counts were established under a light microscope and
expressed as number of parasites per milliliter of blood. All animal
work was conducted in accordance with relevant national and
international guidelines (see here below).
Ethics statement
All mice were housed in our animal care facilities in compliance
with European animal welfare regulations. The Institut Pasteur is
member of the Committee #1 of the Comite ´R e ´gional d’Ethique
pour l’Expe ´rimentation Animale (CREEA), Ile de France. The
Animal housing conditions and protocols used in the present work
were previously approved by the ‘‘Direction des Transports et de
la Protection du Public, Sous-Direction de la Protection Sanitaire
et de l’Environnement, Police Sanitaire des Animaux’’ under the
number B 75-15-28 accordingly to the Ethics Chart of animal
experimentation which includes appropriate procedures to
minimize pain and animal suffering. PM has permission to
perform experiments on vertebrate animals #75-846 issued by the
Department of Veterinary Services of Paris, DDSV and is
Author Summary
While most research efforts have focused on T. b. brucei
trypanosomosis, infections caused by T. vivax and T.
congolense which predominate in livestock and small
ruminants have been subject to little study. In order to
circumvent the major constraints inherent to studying T.
vivax/host interactions in the field, we developed in vivo
murine models of T. vivax trypanosomosis. We show here
that the mouse experimental model reproduce most
features of the infection in cattle. More than reflecting
only the main parasitological parameters of the animal
infection, the mouse model can be used to elucidate the
immunopathological mechanisms involved in parasite
evasion and persistence, and the tissue damage seen
during infection and disease. Studies planned for the
future will allow us to further investigate T. vivax–induced
immunopathology in an experimental context for which all
the necessary tools are now available.
T. vivax Experimental Infection
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personally or under her direction in the framework of laws and
regulations relating to the protection of animals.
Hematology
50 ml of retro-orbital blood were recovered onto 0.5 M EDTA.
Samples were analyzed in a Scil Vet abc (Scil, Strasbourg, France)
using pre-established and normalized parameters for the different
mouse strains. Peripheral reticulocytes were counted as described
[35], modified by S. Bagot (personal communication). Briefly, 5 ml
of blood were fixed in 1 ml of 0.25% glutaraldehyde in PBS
pH 7.4 and further stained with 1 mM Hoechst 33258/Thiazole
orange 0.1 mg/ml in PBS pH 7.4 for 1 h at 37uC.
Histopathology
Twenty days after infection, mice were anesthetized with an i.p.
injection of 0.1 ml per 10 g mouse body weight of a solution
containing 1 mg/ml xylazine (Rompun 2%, Bayer, Leverkusen,
Germany) and 10 mg/ml ketamine (Imalge `ne 1000, Merial, Lyon,
France), and then sacrificed by cervical dislocation. After a
complete post-mortem examination, the spleen, liver, kidneys,
lung, heart and specimens of the central nervous system were
removed and immediately fixed in 10% neutral-buffered formalin.
Tissue samples from these organs were embedded in paraffin; five-
micrometer sections were cut and stained with hematoxylin and
eosin (HE).
Statistical analyses
All the experiments were performed two or three times using at
least 5 mice per experimental group and per time point. Mice were
analyzed individually and the differences between the groups used
in this study were tested for statistical significance using Student’s
test or the Log-rank (Mantel-Cox) test whenever appropriate
(Prism software, Graph Pad, San Diego, CA). Data are expressed
as arithmetic means are presented as arithmetic means +/2 the
standard deviation (SD) of the means.
Results
Trypanosoma vivax molecular and phenotypic
characterization
The IL 1392 West African stock of T. vivax is derived from the
Nigerian isolate Zaria Y486 [23] which is infective for rodents and
can be cyclically and/or mechanically transmitted [36,37].
Rodent-infective derived clones of Y486 T. vivax, notably the IL
1392, have already been shown to express VSG ILDat 1.2
(ILRAD Duttonella antigen type 1.2) [19,28,38,39] in a relatively
stable fashion. This VSG can be readily recognized by its specific
20 amino acid N-terminal sequence (ANNFAETDMEGVCT-
GALTLR) [30,31]. As can be seen in Figure 1A, VSG-1.2 forward
and VSG-1.2 reverse oligonucleotide primers were deduced from
the full length ILDat 1.2 gene sequence and flanking this 20 amino
acid specific sequence. PCR reactions were then used to ascertain
the identity of the initial IL 1392 T. vivax stabilate used in the
present work, as previously shown [30,31]. VSG-1.2F and VSG-
1.2R primers amplified a 148 bp fragment of genomic DNA in IL
1392 bloodstream forms, and when sequenced, this showed more
than 99% similarity with ILDat 1.2 and only 2 point mutations as
compared to Zaria Y486 (See Fig. 1B), confirming the presence of
ILDat 1.2 VSG from the rodent infective West African T. vivax
1392 isolate, not reactive with Eastern T. vivax strains or with DNA
from T. brucei and T. congolense [27,28,40] It is also worth noting
that a PCR reaction comprising TvDNAF (forward) and
TvDNAR (reverse) oligonucleotides amplified a 1,8 kb DNA
product whose sequence was flanked by the two primers and
presented 95% homology to the highly specie-specific ribosomal
promoter of the Y486 T. vivax reference strain (not shown).
Furthermore, we recently showed that the IL 1392 T. vivax
genome possesses a functional proline racemase gene (TvPRAC)
that is absent in other trypanosomatid genomes [34]. Altogether
these results established and confirmed the molecular identity of
the IL 1392 T. vivax parasites used in the present work.
IL 1392 T. vivax bloodstream forms readily infected all mouse
strains tested and were regularly maintained hereafter in the
laboratory without losing infectivity through weekly passages in 7-
to 8-week-old outbred Swiss (outbred) mice (CD-1, RJOrl:SWISS)
(Janvier, France) by intra-peritoneal (i.p.) injection of 10
3 parasite
forms. As can be seen in Figures 1C and 1D, the parasites showed
a predominantly slender morphology, an anterior free flagellum
and a narrow posterior end containing a large sub terminal
kinetoplast, similar to stained trypanosomes from cattle, as
previously described [10,23]. Figure 1E shows large numbers of
T. vivax in blood, at the peak of parasitemia in outbred mice.
Comparison of in vivo infections in mouse strains using
T. vivax Y486-derived IL 1392 stock
Despite the high degree of gene synteny observed in
kinetoplastids, genes coding for essential proteins associated with
key metabolic reactions are not necessarily ubiquitous among
members of the order. Accordingly, T. vivax but not Trypanosoma
brucei, Trypanosoma congolense nor Leishmania spp possesses a TvPRAC
enzyme responsible for the interconversion of L- and D-proline
enantiomers [34]. This enzyme, earlier described in Trypanosoma
cruzi parasites, was shown to be essential for parasite metabolism
and triggers non-specific polyclonal B cell responses in the host
thus contributing to mechanisms of parasite escape from the host
immune system [41,42]. Taking into account the fact that T. vivax
multiplies extracellularly in the host bloodstream, unlike the
intracellular and extracellular T. cruzi, it is conceivable that
TvPRAC may also play a role in triggering non specific polyclonal
B cell responses, contributing to antibody diversity, host
immunosuppression, parasite evasion and persistence. In an
attempt to further address these questions, we decided to develop
a reliable and consistent mouse model and for this purpose studied
several parasitological, hematological and immunological param-
eters of the infection using a parasite stock of defined antigenic
identity.
The experimental murine infection was initially studied using 7
to 8-week-old intact BALB/c inbred mice infected with different
inocula (10
1 to 10
5) of ILRAD 1392 T. vivax bloostream forms.
The initial results showed that appearance of parasitemia was
highly dependent upon the number of parasites injected as
parasites could be detected as early as two days post-injection
when a high inoculum (10
5) was used, while three to six days were
necessary when lower parasite numbers were injected (10
1 to 10
4)
(not shown). Death seemed to correlate with parasite load since
average time to death was also dependent on the number of
parasites in the inoculum (not shown). Thus, the more elevated the
parasite inoculum, the lower the survival rate, corroborating
published data based on the original parasite isolate [43].
In order to compare the impact of host genetic background on
the establishment of infection, we then conducted studies using
BALB/c (H2
d), another inbred mouse strain (C57BL/6) which
bears a different haplotype (H2
b), and an outbred mouse stock, all
infected with an inoculum consisting of 10
2 bloodstream forms of
T. vivax. BALB/c mice showed a rapid and pronounced increase in
parasitemia that reached 4.10
8 parasites/ml, as recorded by daily
monitoring (Fig. 2A). As compared to BALB/c and C57BL/6,
T. vivax Experimental Infection
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4 par-
asites/ml) was slightly delayed following infection of the outbred
mice (Figures 2B and 2C). While parasitemia in all three mouse
strains reached maximum levels 6 to 8 days post-infection, survival
rates were significantly higher in the C57BL/6 and outbred mice
than in the BALB/c mice which died in the first week of infection
(Figure 2D). Moreover, while outbred mice showed a parasitemia
plateau after 10 days of infection, recurrent parasitemia peaks
were observed in the C57BL/6 mice over the same period, as also
observed by De Gee et al. [7] and Mahan & Black [19], indicating
that the C57BL/6 mice were partially controlling the parasite
load.
T. vivax experimental infection results in major changes
in hematological parameters
Since BALB/c mice proved to be highly susceptible to the
infection, we continued our studies using only C57BL/6 and
outbred mice as these were able to endure the infection over a
longer period of time. Microscopic examination of the peripheral
blood of infected animals indicated an apparent loss of red blood
cells, concomitant with high levels of parasitemia. To monitor this
phenomenon, peripheral blood samples taken from individual
mice were analyzed throughout the infection and subjected to
hematological analysis. Complete blood counts showed similar and
severe changes in both mouse strains (Figure 3). Firstly,
hemoglobin concentrations were significantly decreased in both
C57BL/6 (from 13.360.1 to 5.761.0 g/dl) and outbred mice
(14.760.2 to 7.260.6 g/dl). This decrease was associated with a
fall in the red blood cell counts (from 8.560.1 to 3.760.8
10
6 cells/mm
3 and from 9.060.1 to 4.360.4 10
6 cells/mm
3 in the
C57BL/6 and outbred mice, respectively) and in hematocrit
values (from 42.760.5 to 20.663.6% and from 49.660.9 to
25.462.4% in the C57BL/6 and outbred mice, respectively)
(Fig. 3A, 3B and 3C). Taken together, these alterations indicated
that the infection gave rise to severe anemia as reported for natural
cases of bovine trypanosomosis caused by T. vivax [6,44]. An
evaluation made to measure immature red cell production in the
blood showed a transient 5-fold increase in the number of
reticulocytes 14 days post-infection (data not shown). Although
only 20% of the injected animals were still alive 20 days post-
infection, these results suggest that, at the time of death, the mice
were suffering from regenerative, normocytic and normochromic
anemia.
Also, severe thrombocytopenia reported as an universal
complication in the course of trypanosome infections [45] was
observed in both the outbred and C57BL/6 mice, stemming from
a dramatic fall in the platelet count as early as seven to ten days
post-infection (Figure 3D). In addition, and except during the
initial increase in white blood cell counts seen in the first days of
the infection, a leucopenia was observed as the infection
progressed and was more pronounced in the C57BL/6 mice
(Figure 3E). The number of circulating lymphocytes fell signifi-
cantly during the second week of infection, more precisely at
around 20 d.p.i for the outbred mice and was accompanied by an
increase in neutrophils and monocytes, as previously described
with another Y-486 derived strain of T. vivax and albino mice [22]
(see accompanying paper).
Marked to severe liver and spleen lesions
The extent of the tissue damage caused by T. vivax infection was
assessed by means of anatomic pathological and histopathological
examinations. Here, we chose to use the highly reproducible
outbred model as it gave lower inter-individual differences within
the mouse groups and sustained and elevated parasitemia.
Outbred mice were infected with 1610
2 parasites and a general
anatomic pathological assessment of disturbances was conducted
Figure 1. Molecular identity of T. vivax IL 1392. Full lengh of ILDat1.2 VSG gene (A). Initiation and stop codons are underlined. The specific T.
vivax 20-amino acids sequence at the N-terminal end of the gene is depicted in red (positions 64 to 123). Forward and reverse primers used in this
experiment are in italics. DNA was extracted from T. vivax bloodstream forms and amplified by PCR using VSG-1.2F and VSG-1.2R primers. A fragment
of 148 bp was obtained and the resulting sequence aligned with the Y486 reference strain (B). Two point mutations are squared. Blood smears of a
mouse infected with T. vivax were fixed and stained with Giemsa (C and D); k=kinetoplast, f=flagellum. The high number of circulating parasites at
the peak of parasitemia can be evaluated in the picture (E).
doi:10.1371/journal.pntd.0000792.g001
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only in the spleen and liver; the other organs were macroscopically
normal. The spleens were uniformly enlarged, thereby character-
izing marked splenomegaly, but did not show any congestion.
They were firm and a little blood oozed from the cut surfaces.
Randomly scattered white or red foci, ranging from 1 to 5 mm in
diameter were observed on the capsules and the cut surfaces.
Livers showed discrete, pale red or sometimes white foci that were
sharply delineated from the adjacent parenchyma. These foci
varied in size from 0.5 to 2 mm.
Histopathological analyses showed an elevated T. vivax
load in the tissues observed along with multifocal
inflammatory infiltrates in different organs,
extramedullary hematopoiesis in the liver and cerebral
edema
The tissues of outbred mice infected with T. vivax were also
subjected to histopathological analysis 20 days post-infection.
Lymphoid and non-lymphoid organs showed significant lesions
(Figure 4). The spleens of infected animals (Figures 4A to 4D),
showed diffuse lesions, more diffuse at the periphery of the organ,
involving both the red and white pulps (Figure 4A). Lesions in the
red pulp were characterized by necrosis with replacement of the
normal tissue by an acidophilic and amorphous to fibrillar
material containing cell debris, fibrin, extravasated erythrocytes
and trypanosomes that were often clustered together in hemor-
rhagic foci (Figure 4B and inset arrowhead). Extramedullar
hematopoiesis foci were reduced in number (Figure 4C). The
white pulp showed disorganized lymphoid structure associated
with marked infiltration by activated macrophages displaying
vesiculous, euchromatic and nucleolated nuclei and abundant
acidophilic cytoplasm. Infiltration by several lymphocytes and
plasma cells was also noted (Figure 4D). Numerous plasma cells
called ‘Mott cells’, characterized by their round shape and a polar
cytoplasm containing stored immunoglobulins (Russel bodies),
were observed in both the red and white pulps (Figure 4D, arrow).
Collectively, these lesions were characteristic of diffuse, sub acute,
necrotizing and hemorrhagic splenitis, associated with intralesional
trypanosomes.
A multifocal to coalescing lesion, primarily centered on the
portal tracts but also involving centrilobular veins, was observed in
the liver (Figure 4E). As can be seen, the lesion was characterized
by marked infiltration of plasma cells, lymphocytes and macro-
phages (Figure 4F). Trypanosomes were frequently observed in the
vascular spaces, i.e. sinusoids and the portal and terminal hepatic
veins. Many necrotic foci were also observed, randomly distributed
in the liver parenchyma and associated with hemorrhages and
trypanosomes (Figure 4F, inset arrowhead). A very high density of
extramedullar hematopoiesis foci was noted in the liver sinusoids
(Figure 4G). Collectively, these lesions were characteristic of
multifocal to coalescing necrotizing and hemorrhagic hepatitis,
associated with extramedullary hematopoiesis and intralesional
trypanosomes.
The infection also induced bilateral, multifocal and sub acute
tubulointerstitial nephritis, as can be seen in Figures 4H to 4J. The
kidneys showed bilateral multifocal lesions, mostly involving the
renal cortex and characterized by interstitial perivascular and
periglomerular infiltration of plasma cells, lymphocytes and
Figure 2. Effect of host background on parasite load and fate.
BALB/c, C57BL/6 or Outbred mice were injected i.p. with 1610
2
bloodstream forms of T. vivax and the mean parasitemia recorded
individually during infection (A, B, C). Mean mortality (D) is depicted
compared to BALB/c mice. Results are given as arithmetic means 6
standard deviations of at least three independent experiments. Cumula-
tive mortality was recorded over time for all groups and Kaplan-Meir
survival curves plotted for the three mouse strains (D); Comparison
between survival curves was performed using Log-rank Mantel-Cox test: *
p,0.028, ** p,0.0018, when compared with BALB/c survival.
doi:10.1371/journal.pntd.0000792.g002
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in this lesion. Some randomly distributed tubular epithelial cells
were noted, showing acidophilic cytoplasm and a condensed hyper
basophilic (pycnotic) and/or fragmented nucleus (necrotic cells).
Trypanosomes were observed in the blood vessels, mostly in the
arcuate arteries at the corticomedullary junction (Figure 4J, star
and 4J, inset arrowhead).
The histopathological investigation of the central nervous system
also discovered multifocal lesions centered primarily on small and
medium-sized veins,and more severein thecerebellum(Figure 4K).
Evidence was often noted of dilatation and filling of the blood vessel
lumen by erythrocytes, proteins and numerous trypanosomes.
Vasogenicedema was observed,characterizedby the presence of an
amorphous and unstained material accumulated in perivascular
spaces. Some angular and shrunken neurons close to these lesional
blood vessels contained acidophilic cytoplasm and a condensed
hyper basophilic nucleus, characteristic of ischemic necrosis
(Figure 4L). Trypanosomes were also seen in the meningeal blood
vessels (Figure 4M, star and inset, arrowhead).
Interestingly, and although observed in only a few animals,
moderate lymphoid hyperplasia was noted in the lymph nodes,
apparently associated with intravascular or intrasinusal trypano-
somes, as previously described in ruminants [46] (not shown). In
addition, histopathological examination of the heart, revealed the
presence of numerous parasites in the ventricular cavities as well as
in the blood vessels located in the periphery of the myocardium in
some mice. Some of these lesions were accompanied by an
infiltration of mononuclear cells (multifocal myocarditis), i.e.
plasmocytes, lymphocytes and macrophages. These findings are
suggestive of a myocardial commitment induced by the infection
and are consistent with the congestive heart failure that has
previously been reported for cattle trypanosomosis [26,47,48].
Discussion
While Human African Trypanosomiasis (HAT) has drawn the
attention of many research groups over the last three decades, lesser
consideration has been given to animal trypanosomosis (Nagana)
despite its considerable impact on the development and fertility of
livestock and the economical hardship it causes in several countries.
Most studies, both in the distant past and more recently, have
concentrated on analyzing the genetic factors involved in tolerance
to trypanosomosis, or on describing the general deregulation of the
immuneresponseasexpressedbyafewindividualsindifferentcattle
Figure 3. T. vivax induces major perturbations in hematological parameters and causes severe thrombocytopenia. 8-week-old
Outbred (white symbols) or C57BL/6 (black symbols) mice were injected i.p. with 1610
2 bloodstream forms of T. vivax. Blood samples were collected
individually every 2–3 days and red blood cell counts (RBC, A), hematocrit (HCT, B), hemoglobin concentrations (HGB, C), leukocytes (WBC, D) and
platelets (PLA, E), were determined. Results are given for days 5, 10, 15 and 20 as arithmetic means 6 standard deviations of at least three different
experiments with 3–5 mice per time point/experimental group. *** p,0.001, ** p,0.01, * p,0.05, when compared with samples from day 0. $=not
determined on day 10 for C57BL/6 mice.
doi:10.1371/journal.pntd.0000792.g003
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www.plosntds.org 6 August 2010 | Volume 4 | Issue 8 | e792Figure 4. Histopathological study of mice infected with Trypanosoma vivax. 8-week-old Outbred mice were injected i.p. with 10
2
bloodstream forms of T. vivax and different lymphoid and non lymphoid organs were harvested for histopathological examination 20 days post-
infection. Spleen (A–D): (A) Diffuse lesions characterized by large necrotic foci in the red pulp (black star), associated with lymphoid tissue
disorganization in the white pulp (white star). (B) Infiltration of a necrotic focus by activated macrophages (top of the Fig., arrows) and trypanosomes
(arrowhead shows very small basophilic points in the inset depicting a higher magnification). (C) Presence of lower density hematopoiesis compared
to non-infected mice. (D) Infiltration of the white pulp by activated macrophages and presence of a Mott cell (arrow). Liver (E–G): (E) Multifocal
inflammatory lesions centered on portal tracts/centrilobular veins (arrows), and focal necrotic focus (star). (F) Peri-venous inflammatory infiltrate
composed of plasma cells (mostly), but also lymphocytes and macrophages. In the inset depicting a higher magnification, arrowhead points to
trypanosomes in the vascular spaces. (G) Foci of extramedullary hematopoiesis. Kidney (H–J): (H) Interstitial inflammatory infiltrates (I) mostly
composed of plasma cells. (J) Trypanosomes in an arcuate artery (star); in the inset depicting a higher magnification, arrowhead points to
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brucei, which is of little clinical importance in livestock, has generally
constituted the parasite of choice in experimentally and genetically
controlled studies [57,58,59,60]. But trypanosomosis, which is
overwhelmingly the most prevalent cattle illness in Africa and South
America,ismainlycausedbyT.vivaxandT.congolense. The hallmark
of their pathogenesis in the field is severe anemia accompanied by a
general immunosuppressive condition [6,21]. Since various types of
tissue damage have been described for ruminants, horses, sheep and
goats, distinct strategies are used to explain host resistance
(‘‘tolerance’’?) or susceptibility to trypanosomes and/or the etiology
of the lesions and tissue damage observed [20,25,61,62,63]. To
overcome these difficulties, several experimental models were
developed in rats and mice (see [21] for a review). Athough these
studies showed that the mouse was potentially an important tool in
understanding the pathogenesis of trypanosomosis and most
particularly the immunobiology of host-parasite interactions, most
subsequent studies focused on trypanosomes of the subgenus
Trypanozoon (i.e. T. brucei) leaving T. (Duttonella) vivax infections
poorly characterized. Thus, despite the fact that remarkable
progress was made, the array of features shown by diverse stocks
of T. vivax isolates has not painted a clear picture of the factors that
could be central to the development of appropriate immuno(che-
mo)therapies [15,64].
To better investigate the relationship between trypanosomosis
and genetically-controlled rodents, we therefore undertook to
develop new mouse models of Trypanosoma (Dutonnella) vivax
infection. This parasite not only differs from other trypanosomes
belonging to the Trypanozoon subgenus (i.e. T. brucei and T.
equiperdum, but not T. evansi) with regard to its transmission and
tissue distribution in the host, but also is generally recognized as
possessing diverse isolates which may or not express the ability to
infect laboratory rodents [10,23,36,65]. For instance, East African
isolates are known to induce mild infections and hemorhagic
syndromes in cattle and only some stocks are adapted to rodents.
Conversely, West African T. vivax isolates, obtained at different
stages of natural infection, are responsible for the majority of
trypanosomosis cases in cattle and other ruminants and may
express mild, intermediate or high virulence to mice [7,65]. The
work presented here used a well characterized West African T.
vivax isolate which is infective to rodents (IL 1392)
[19,23,28,31,38,39] and describes in detail the parasitological,
hematological and histopathological parameters of the infection in
different inbred and outbred mouse strains. IL 1392 was chosen
for its stable expression of VSG ILDat 1.2, characteristic of
rodent-adapted West African T. vivax isolates that together with
closely related South American stocks pertain phylogenetically to
the same clade [66]. Initially, our studies showed that the IL 1392
isolate, retained its infective characteristics and mouse infection
profile after a long cryopreservation period (see Material and
Methods) [11,22]. In addition, the experimental mouse models
used in this work proved easy to handle on infection and reflected
the general characteristic features observed in livestock, namely
the remodeling of secondary lymphoid organs, cardinal severe
anemia, genetically-related differences in resistance to the parasite
(but not to death) and the development of multifocal tissue
hemorrhages, necrosis and consequent systemic pathologies.
Briefly, the work confirmed widespread observations that BALB/
c mice are highly susceptible to T. vivax infection with the shortest
survival time as compared to C57BL/6 or outbred mice.
Furthermore, the BALB/c but also C57BL/6 and outbred
experimental mouse models showed an early exponential increase
in parasitemia, closely resembling acute trypanosomosis in the field
[46]. Regardless of the fact that C57BL/6 and outbred mice proved
to be more ‘‘tolerant’’ than BALB/c to T. vivax, limiting the
pathological consequences of the infection and delaying mortality,
all the mice presented common pathognomonic signs of the disease,
such as anemia, cachexia, thrombocytopenia associated with high
parasitemia and a tendency to leucopenia in the terminal stages
[22,45,67]. As frequently observed in cattle and goats infected by T.
vivax, the histopathological analysis of mouse tissues committed by
the infection showed accumulation of trypanosomes nuclei and
debris in the blood vessels of mouse spleen, liver and brain. Some
extravascular foci associated with intense inflammatory and
degenerative tissue disorders and cerebral edema were also
observed [5,22,68]. It is noteworthy that both the red and white
pulps of the spleen showed severe necrosis, with germinal centers
depleted of lymphocytes, which could explain the lymphopenia
observed at late stages in the infection. The marked splenitis,
hepatitis and central nervous system involvement with vasogenic
oedema and ischemia, reflect to what extent the model is of value in
studies of T. vivax pathogenesis. The characteristic erythrocytopenia
experienced at the peripheral level is suggestive of a decreased
erythropoiesis. However, we cannot rule out possible extravascular
haemolysis, or more specific apoptosis due to an autoimmune
process triggered by the infection. A detailed study of bone-marrow
cell populations before and during the infection will better address
these questions (see accompanying paper).
The present systematic analysis described here using different
mouse strains infected with a well characterized West African T.
vivax isolate showed that these models are reliable and constitute
new experimental tools for the study of trypanosomosis. The studies
conducted aimed to develop models that could be used in the future
to gain further insight into the genetic mechanisms involved in drug
resistance and the discovery of new drug targets for purposes of
parasite control. However, further studies using Eastern or other
Western T. vivax stocks and the present mouse strains are
encouraged to better approach the influence of genetic parasite
divergences on disease outcome. These models of infection will be
useful in the in vivo testing of new chemicals against T. vivax
trypanosomosis since tests in the definitive hosts are prohibitively
expensive. Finally, the mouse models given herein provide a
description of the parasitological, hematological and histopatholog-
ical features of T. vivax infection and pave the way to a more in-
depth understanding of the immune responses involved in disease
tolerance and susceptibility to T. vivax.
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